Type 1 diabetes trials in Argentina

5 of 6 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

  Where

  Buenos Aires, Córdoba, Mar del Plata, Salta, San Miguel de Tucumán, Santa Fe

  Age

  1 year to 25 years

  People

  723 worldwide

  Run by

  Sanofi

  See details and how to joinNCT07088068
• Phase 3Taking people
  A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

  Where

  Buenos Aires, CABA, Ciudad de Buenos Aires, Ramos Mejía, Rosario, San Nicolás

  Age

  18 years and over

  People

  500 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07776509 · EU 2025-523295-23-00
• Phase 3Taking people
  A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

  Where

  Buenos Aires, Ciudad de Buenos Aires, Mendoza, Ramos Mejía, Rosario, San Nicolás

  Age

  18 years and over

  People

  2,500 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07784725 · EU 2025-523379-41-00
• Phase 3Not yet taking people in Argentina
  A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

  Where

  Buenos Aires, CABA, Capital Federal, Ciudad Autónoma de Buenos Aires, Ciudad de Buenos Aires, San Miguel de Tucumán, Santa Fe, Santiago del Estero

  Age

  18 years and over

  People

  2,500 worldwide

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT07564414 · EU 2025-522488-14-00
• Phase 3Not yet taking people in Argentina
  AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

  Where

  Bahía Blanca, Buenos Aires, CABA, Ciudad Autonoma de Buenos Aires, Ciudad Autónoma de Buenos Aires, Córdoba, Godoy Cruz, Mar del Plata, Rosario, San Juan, San Miguel de Tucumán, San Rafael

  Age

  45 years and over

  People

  1,778 worldwide

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT07797335